Skip to main content
. 2023 Jun 14;29(22):3508–3518. doi: 10.3748/wjg.v29.i22.3508

Table 1.

Demographic and clinical data of patients according to eradication outcome

Outcome
Successful
Failed
P
N 365 29
Age (mean ± SD) 45.90 ± 13.95 52.5 ± 12.2 0.319
Age range (20-77) (27-68)
Age (≤ 50) 221 15 0.046
Gender (M/F) 122/243 44/74 0.685
Smoking (Yes/No) 31/334 5/29 0.168
Drinking (Yes/No) 61/304 8/29 0.138
Education 0.099
    Primary school 61 19
    Middle school 138 40
    College 158 57
GC family history 0.361
    Yes/No 15/350 2/27
Endoscopy diagnosis 0.597
    Gastritis 247 22
    Ulcer 45 2
    Unknown 73 5
Intestinal metaplasia 0.557
    No 176 17
    Yes 113 7
    Unknown 76 5
Treatment 0.959
    500 mg b.i.d. 145 12
    750 mg b.i.d. 110 8
    500 mg t.i.d. 110 9
Treatment line1 0.026
    First line 291 18
    Rescue therapy 74 11
PPI 0.762
    Pantoprazole 151 14
    Esomeprazole 69 4
    Rabeprazole 139 11
    Lansoprazole 6 0
Bismuth 0.351
    Bismuth potassium citrate 302 22
    Colloidal bismuth pectin 63 7
Type 2 diabetes 18 6 0.020
Hypertension 48 15 < 0.0001
Hyperlipidemia 19 7 < 0.0001
Penicillin allergy 70 6 0.843
1

Recording this treatment as start of frequency. Rescue therapy was defined as patients who had eradicated therapy once or more but failed.

P values were from two-side comparisons the differences between two groups. M: male; F: female; 500 mg b.i.d.: Tetracycline twice daily; 750 mg b.i.d.: Tetracycline twice daily; 500 mg t.i.d.: Tetracycline three times daily.